How Cannabis Affects Your Reaction Time

Explore the neurological process by which cannabis slows response times and the key factors, from dosage to tolerance, that alter this cognitive effect.

Cannabis reliably slows reaction time during the acute high, though the size of the effect depends heavily on how often you use it and what else is in your system. In a controlled study comparing groups after inhaling cannabis, occasional users saw their reaction times worsen by roughly 17 milliseconds on average, while daily users showed almost no measurable change. That gap between casual and habitual users turns out to be one of the most consistent findings in the field, and it reshapes how scientists think about cannabis impairment more broadly.

The Acute Slowdown

When researchers measure reaction time in a lab setting, they typically ask participants to respond to a stimulus on a screen as quickly as possible. The task sounds trivial, but it captures the speed of the entire chain from perception to muscle movement. A study that compared sober controls, occasional cannabis users, and daily users on a tablet-based reaction time task found that sober participants actually got faster between their pre- and post-assessment sessions (improving by about 21 milliseconds, likely from practice). Occasional users, by contrast, got slower by about the same amount after inhaling cannabis. Daily users fell somewhere in between, with no statistically meaningful change in either direction.

Those numbers may sound small in isolation. A 17-millisecond shift is roughly the time it takes a car traveling at highway speed to cover an extra foot or two. But reaction time tasks in the lab strip away the complexity of real situations. When you are driving, playing a sport, or operating equipment, the relevant decisions are more complicated than tapping a screen, so the real-world consequences of even a modest slowdown can multiply quickly.

Why Frequent Users Seem Less Affected

One of the strongest patterns in this research is that people who use cannabis regularly show substantially less impairment on psychomotor tasks than people who use it occasionally. A study that gave both heavy and occasional cannabis users the same dose of THC found that occasional users were significantly impaired on critical tracking, divided attention, and impulse-control tasks, while heavy users were largely unaffected except on the impulse-control measure. A separate study looking at smoked cannabis confirmed this, finding that occasional smokers had significantly more trouble on tracking tasks about 90 minutes after smoking compared with frequent smokers.

This is classic pharmacological tolerance: the brain adjusts to repeated exposure. A broader analysis found that cannabis-induced impairment on critical tracking tasks decreased as participants’ frequency of past cannabis use increased, while there was no main effect of use history when people were sober. In practical terms, a daily user and an occasional user who smoke the same joint are not equally impaired, and the difference can be dramatic. That said, tolerance does not mean zero impairment. Even heavy users still showed slowed impulse-control responses at higher THC concentrations, suggesting that some cognitive functions remain vulnerable regardless of use history.

What This Means for Driving

Driving is the context most people worry about, and the research consistently points in one direction: cannabis makes you a slower, less responsive driver. In a driving simulator study, marijuana significantly increased crash-avoidance reaction times, with the effect peaking between two and three hours after ingestion. The slowdown was measurable even at blood THC concentrations well below the legal cutoffs used in many states.

Epidemiological data backs this up. A meta-analysis found that cannabis-impaired driving was associated with about a 36 percent increase in crash risk, a statistically significant effect described by the researchers as low-to-moderate in magnitude. A more recent systematic review and meta-analysis put the figures in sharper terms: cannabis consumption was linked to roughly 14 additional traffic deaths per 100,000 crashes, and an absolute increase in crash-injury risk of about 7 percent. These numbers are lower than those associated with alcohol, but they are not trivial. Cannabis impairment on the road is real, even if it does not produce the dramatic swerving and loss of control that heavy drinking does. The pattern tends more toward delayed reactions and difficulty managing unexpected events.

Mixing Cannabis and Alcohol

If cannabis alone slows you down, combining it with alcohol appears to make things worse in a roughly additive way. A study examining driving simulation under cannabis alone, alcohol alone, and the combination found that the two substances together increased both lane weaving and reaction time more than either drug on its own, along with stronger subjective feelings of intoxication. This is worth emphasizing because the combination is common. People who use cannabis socially often do so alongside a drink or two, and the interaction is not one where the effects cancel out. They stack.

The practical takeaway here is straightforward: if you are trying to gauge whether you are safe to drive or handle anything requiring fast reflexes, adding even a moderate amount of alcohol on top of cannabis use pushes the risk meaningfully higher than either substance alone would.

The CBD Question

Many cannabis products are marketed as high in CBD and low in THC, with the implication that they are “functional” or less impairing. The evidence on CBD’s effect on reaction time is genuinely reassuring on this point, but with a caveat. A meta-analysis comparing CBD to placebo and to THC found that while CBD produced a small overall effect on performance measures in aggregate, the effect was driven entirely by subjective feelings of drowsiness. On objective measures of psychomotor ability, attention, driving performance, and information processing, CBD did not differ significantly from placebo.

The caveat is about what CBD does not do. A popular idea holds that CBD can counteract THC’s impairing effects, offering a sort of built-in safety net in products with both cannabinoids. A controlled trial tested this directly by giving healthy volunteers CBD before THC and found that pre-treatment with CBD did not reduce THC’s negative effects on cognition or attention. So a product high in both CBD and THC is not likely to spare your reaction time compared to one with the same amount of THC alone. CBD on its own seems fine for psychomotor function, but it should not be thought of as an antidote when THC is also on board.

Why Blood THC Levels Are a Poor Measure of Impairment

Alcohol impairment maps reasonably well onto blood alcohol concentration. Cannabis does not work this way, and it creates real problems for testing and law enforcement. The relationship between blood THC levels and actual cognitive or psychomotor impairment is weak and often paradoxical. A study giving participants both oral and vaporized cannabis found that after eating cannabis, blood THC concentrations often stayed below the legal per se limits used in some states, even while participants showed clear cognitive impairment. After vaping, the opposite happened: blood THC spiked immediately and then crashed, frequently falling below detection limits before the subjective and cognitive effects had worn off. Some participants had very high blood THC right after vaping yet showed no measurable impairment at all.

Other studies have confirmed this disconnect. One found that the linear relationship between the magnitude of performance impairment and THC levels in either blood or oral fluid was low. Another, focusing specifically on heavy chronic smokers, found no significant differences in critical-tracking or divided-attention performance despite measurable whole blood THC, and concluded that existing tools for quantifying cannabis-related psychomotor impairment were not precise enough to determine recent use with accuracy.

This matters for two reasons. First, roadside blood or saliva tests can flag someone as “positive for THC” long after any impairment has passed, especially in regular users whose body fat slowly releases stored THC. Second, someone who has just consumed an edible might test under the legal limit while being genuinely impaired. The science says THC blood levels are a poor proxy for reaction-time deficits, and any legal framework that treats them like blood alcohol levels is working with a blunt tool.

How Long Does the Impairment Last

The acute window of impairment from inhaled cannabis is generally understood to run from the first few minutes through roughly three to four hours after use, with the peak effect typically occurring within the first hour or two. Edibles present a different curve: the onset is slower (often 30 to 90 minutes), the peak comes later, and the overall duration of effects stretches longer because the gut and liver process THC more gradually than the lungs do. The driving simulator data mentioned earlier showed reaction times still significantly elevated at 180 minutes after ingestion.

A question many users have is whether impairment lingers into the next day. A systematic review looked at this directly, examining 345 performance tests from 20 studies that assessed participants more than 12 hours after a single THC dose. The majority of those tests showed no next-day effects. The small number that did find next-day impairment came from older, less rigorously designed studies. The review authors noted that roughly a quarter of the tests that showed no next-day impairment had also failed to find acute impairment in the first place, suggesting the doses or tasks in those particular experiments may not have been sensitive enough to catch any effect. The bottom line from the available evidence is that a single dose of cannabis is unlikely to impair your reaction time the morning after, though the evidence is not iron-clad and individual variation is real.

Workplace and Occupational Implications

Outside of driving, the reaction-time question has clear implications for anyone working in safety-sensitive environments. A scoping review of systematic reviews on medicinal cannabis and workplace safety concluded that adverse effects of cannabis use could decrease alertness and reaction times, reduce the ability to safely operate machinery, and increase the probability of falls. A study of workers who used cannabis found that use was associated with lower alertness, slower response organization, and working-memory problems at the start of the week, with psychomotor slowing becoming more apparent by the end of the week. Interestingly, cannabis-using workers did not report more actual workplace errors than controls, which may reflect self-monitoring or task selection rather than true absence of risk.

The gap between measurable impairment and self-reported errors is worth noting. People who are mildly slowed may compensate by being more cautious, choosing easier tasks, or working at a slower pace. That compensation strategy works until it doesn’t, which is why safety-critical industries continue to treat cannabis as a disqualifying substance for on-duty use regardless of whether the employee is a daily user who has developed tolerance.

Athletic and Physical Performance

Some athletes use cannabis for recovery, anxiety management, or pain relief, and the question of whether it hurts on-field performance comes up regularly. A review in a major sports medicine journal concluded that research into whole cannabis and THC has generally shown either no effect or a harmful effect on exercise performance in both strength and aerobic activities, with no evidence of any performance-enhancing benefit. This aligns with what the reaction-time data would predict: anything that slows stimulus processing and motor response is unlikely to help in activities that demand quick decision-making and coordination.

That said, the research on cannabis and exercise is thinner than you might expect. Most studies use recreational users rather than trained athletes, and the doses, products, and timing vary widely. What the evidence does consistently show is that cannabis is not going to make you faster or more reactive, and in sports where split-second decisions matter, it could plausibly hurt.

The Route of Administration Wrinkle

How you consume cannabis changes the timing and possibly the magnitude of its effects on reaction time, and this is an area where the science still has gaps. Smoking and vaping deliver THC to the brain within minutes, producing a rapid spike in blood THC that correlates roughly with the fast onset of subjective and cognitive effects. Edibles take much longer to kick in but produce a more prolonged curve of exposure. A review of the literature on cannabis and driving performance flagged the route of administration as one of the critical under-researched variables, asking whether the lower peak THC levels associated with edibles result in smaller impacts on performance, and how long potential impairment persists along the different time courses of different delivery methods.

The study comparing oral and vaporized cannabis noted earlier demonstrated part of this complexity: the mismatch between blood THC levels and actual impairment was more pronounced with oral consumption, where participants were impaired despite low blood levels. For the person deciding when it is safe to drive after an edible, the delayed and extended time course is a genuine trap. You might feel the peak has passed when the cognitive effects are still going strong, and because blood THC never climbed very high to begin with, even a hypothetical roadside test might not flag you. The safest approach for edibles is to assume a longer window of potential impairment than you would expect from smoking, and to plan accordingly.

Individual Variation and What the Research Cannot Capture

Nearly every study in this area reports large individual variability. Some people show dramatic reaction-time deficits at low THC doses; others show almost none at high ones. Body composition matters because THC is fat-soluble and distributes differently depending on how much adipose tissue you carry. Genetics play a role too: variations in the enzymes that metabolize THC mean that the same dose produces different blood concentrations in different people. Sleep quality, caffeine intake, stress, and whether you ate recently all modulate baseline reaction time before cannabis even enters the picture.

This variability is one reason researchers are cautious about declaring a universal “safe” dose or “safe” waiting period. The median finding in the research may be a 15-to-20-millisecond slowdown in occasional users, but some individuals fall well outside that range. If you are using cannabis and planning to do anything that demands fast reflexes, the honest scientific message is not “wait X hours and you will be fine.” It is that the duration and severity of impairment vary enough from person to person that conservative margins are worth building in, especially if you are not a daily user and thus have not developed the tolerance that blunts the effect.